H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 15228427)

Published in Int J Gynecol Cancer on July 01, 2004

Authors

V Tanos1, I Ariel, D Prus, N De-Groot, A Hochberg

Author Affiliations

1: Department of Biological Chemistry, Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel. tanosv@spidernet.com.cy

Articles citing this

The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37

Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene (2014) 1.20

H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol (2005) 0.99

miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer. Oncotarget (2015) 0.94

H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO Mol Med (2015) 0.94

Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis. Cancers (Basel) (2015) 0.87

CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc. Oncotarget (2015) 0.87

The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Cancer Med (2016) 0.86

Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol (2015) 0.86

Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR. BMC Cell Biol (2013) 0.86

Long Non-Coding RNAs in Endometrial Carcinoma. Int J Mol Sci (2015) 0.84

Elevated expression of H19 and Igf2 in the female mouse eye. PLoS One (2013) 0.82

Dysregulated expression of long noncoding RNAs in gynecologic cancers. Mol Cancer (2017) 0.75

Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene. Cell Cycle (2016) 0.75

Understanding of leukemic stem cells and their clinical implications. Mol Cancer (2017) 0.75

H19 promotes endometrial cancer progression by modulating epithelial-mesenchymal transition. Oncol Lett (2016) 0.75

Articles by these authors

Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes (2000) 2.75

The non-coding RNAs as riboregulators. Nucleic Acids Res (2001) 2.11

The streaming liver. II. Hepatocyte life history. Liver (1988) 2.06

Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG (2011) 1.77

Non-coding, mRNA-like RNAs database Y2K. Nucleic Acids Res (2000) 1.57

Regulatory RNAs. Cell Mol Life Sci (2001) 1.56

Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol Pathol (1998) 1.52

Parasitic ovarian dermoid tumor of the omentum-A review of the literature and report of two new cases. Eur J Obstet Gynecol Reprod Biol (1998) 1.52

Recurrent tetraamelia and pulmonary hypoplasia with multiple malformations in sibs. Am J Med Genet (1991) 1.52

Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46

Thomas syndrome: potter sequence with cleft lip/palate and cardiac anomalies. Am J Med Genet (1996) 1.43

p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes (2001) 1.42

The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol (2000) 1.41

Primary malignant melanoma of the small intestine and the APUD cell concept. J Surg Oncol (1978) 1.28

The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology (1995) 1.27

Collection of mRNA-like non-coding RNAs. Nucleic Acids Res (1999) 1.22

The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene (1997) 1.18

Parental imprinting of the human H19 gene. FEBS Lett (1992) 1.16

The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol (1997) 1.15

Expression of the imprinted gene H19 in the human fetus. Mol Reprod Dev (1994) 1.14

Growing teratoma syndrome vs chemotherapeutic retroconversion: case report and review of the literature. Gynecol Oncol (2004) 1.14

Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia. J Clin Invest (2000) 1.14

The streaming adrenal cortex: direct evidence of centripetal migration of adrenocytes by estimation of cell turnover rate. J Endocrinol (1986) 1.12

Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer (2006) 1.12

The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Lett (1995) 1.09

Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol (1999) 1.04

Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene (1997) 1.03

Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol Hum Reprod (2004) 1.02

The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol Reprod Dev (1993) 1.02

Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. J Pharmacol Exp Ther (1967) 1.01

Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Ther (2012) 1.01

Germ cell tumors of the ovary arising after dermoid cyst resection: a long-term follow-up study. Obstet Gynecol (1994) 1.00

The streaming liver. III. Littoral cells accompany the streaming hepatocyte. Liver (1988) 0.99

H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol (2005) 0.99

Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection. Am J Med Genet (2000) 0.98

Characterization of human and mouse H19 regulatory sequences. Mol Biol Rep (2000) 0.97

Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. Diagn Mol Pathol (1997) 0.96

Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling. Mol Hum Reprod (2000) 0.96

Developmentally imprinted genes as markers for bladder tumor progression. J Urol (1996) 0.95

Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences. Mol Ther (2003) 0.94

Human imprinted genes as oncodevelopmental markers. Tumour Biol (1994) 0.94

Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone. Cancer Res (1999) 0.94

METABOLIC STUDIES IN PATIENTS WITH CANCER OF THE GASTRO-INTESTINAL TRACT: VII-THE INFLUENCE OF GASTRIC SURGERY UPON THE CHEMICAL COMPOSITION OF THE LIVER. Ann Surg (1942) 0.94

Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta. Mol Reprod Dev (1992) 0.93

Merkel cell tumor masquerading as granulation tissue on a teenager's toe. Am J Dermatopathol (1992) 0.93

Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Mol Ther (2000) 0.93

Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. Clin Cancer Res (1999) 0.92

Synaptogenesis and myopathy under acetylcholinesterase overexpression. J Mol Neurosci (2000) 0.91

The expression of the H19 gene and its function in human bladder carcinoma cell lines. FEBS Lett (1999) 0.91

Relaxation of imprinting in trophoblastic disease. Gynecol Oncol (1994) 0.90

Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod (2000) 0.90

Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90

Echinococcosis presenting as a supraclavicular mass. Successful therapy with mebendazole. Clin Pediatr (Phila) (1982) 0.90

Role of infection in the middle lobe syndrome in asthma. Arch Dis Child (1992) 0.89

H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene (1995) 0.89

METABOLIC STUDIES IN PATIENTS WITH CANCER OF THE GASTRO-INTESTINAL TRACT : X-HYPOPROTEINEMIA AND ANEMIA IN PATIENTS WITH GASTRIC CANCER. Ann Surg (1943) 0.87

Rectal mucosal biopsy in aganglionosis and allied conditions. Hum Pathol (1983) 0.87

Endothelial nitric oxide synthase immunoreactivity in early gestation and in trophoblastic disease. J Clin Pathol (1998) 0.86

The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis (1998) 0.86

Central nervous system involvement in X-linked myotubular myopathy. J Child Neurol (1997) 0.84

Hansenula anomala infections in children: from asymptomatic colonization to tissue invasion. Pediatr Infect Dis J (1991) 0.84

Renal anomalies in Marden-Walker syndrome: a clue for prenatal diagnosis. Am J Med Genet (1995) 0.84

Azoospermia due to testicular amyloidosis in a patient with familial Mediterranean fever. Hum Reprod (2001) 0.84

Salicylate as an in vivo free radical trap: studies on ischemic insult to the rat intestine. Free Radic Biol Med (1991) 0.84

Bromo-adenosine stimulates choriogonadotropin production in JAr and cytotrophoblast cells: evidence for effects on two stages of differentiation. Mol Endocrinol (1991) 0.84

Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer. J Oncol (2010) 0.83

Intrauterine growth restriction and shallower implantation site in rats with maternal hyperinsulinemia are associated with altered NOS expression. Placenta (2009) 0.83

Rectal ulcers: a rare gastrointestinal manifestation of systemic lupus erythematosus. J Clin Gastroenterol (1999) 0.82

A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor. J Immunol (1992) 0.81

Crohn's disease isolated to the appendix: truths and fallacies. Hum Pathol (1986) 0.81

Alpha-smooth muscle actin-positive myofibroblasts in endometrial stroma are not a reliable criterion for the diagnosis of well differentiated endometrioid adenocarcinoma in small tissue samples. Int J Gynecol Pathol (2001) 0.81

Parallel regulation of parentally imprinted H19 and insulin-like growth factor-II genes in cultured human fetal adrenal cells. Endocrinology (1994) 0.81

HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies. Mol Hum Reprod (2000) 0.81

Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod (1996) 0.80

Connective tissue activating peptide III expression disappears progressively with increased dysplasia in human cervical epithelium. Gynecol Oncol (2000) 0.80

Intermediate cells during cytotrophoblast differentiation in vitro. Cell Growth Differ (1993) 0.79

Isolation and characterization of free and membrane-bound polyribosomes from rabbit spinal cord. J Neurosci Methods (1979) 0.79

I.V. Administration of L-GNRH-PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice. Int J Cancer (2001) 0.79

Preleukemia in acute lymphoblastic leukemia. Acta Haematol (1981) 0.79

Eph and ephrin expression in normal placental development and preeclampsia. Placenta (2004) 0.79

Relaxation of imprinting in carcinogenesis. Cancer Genet Cytogenet (1996) 0.79

Tumour of the nose as a presenting feature of leukaemia. J Laryngol Otol (1982) 0.79

A simple and rapid method for staining the enteric ganglia: application for Hirschsprung's disease. J Pediatr Surg (1993) 0.78

Nitric oxide synthase immunoreactivity in human bladder carcinoma. Mol Pathol (2001) 0.78